ZIBCLEO Trademark

Trademark Overview

On Friday, October 23, 2020, a trademark application was filed for ZIBCLEO with the United States Patent and Trademark Office. The USPTO has given the ZIBCLEO trademark a serial number of 90273836. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 29, 2024. This trademark is owned by AbbVie Inc.. The ZIBCLEO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
zibcleo

General Information

Serial Number90273836
Word MarkZIBCLEO
Filing DateFriday, October 23, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 27, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Pseudo MarkZIB CLEO

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 12, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbVie Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAbbVie Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Trademark Events

Event DateEvent Description
Tuesday, October 27, 2020NEW APPLICATION ENTERED
Saturday, December 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 24, 2021ASSIGNED TO EXAMINER
Thursday, March 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 27, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 22, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 22, 2021SOU TEAS EXTENSION RECEIVED
Monday, November 22, 2021SOU EXTENSION 1 FILED
Monday, November 22, 2021SOU EXTENSION 1 GRANTED
Wednesday, November 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 21, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, June 21, 2022SOU EXTENSION 2 FILED
Tuesday, June 21, 2022SOU EXTENSION 2 GRANTED
Thursday, June 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 14, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 14, 2022SOU EXTENSION 3 FILED
Wednesday, December 14, 2022SOU EXTENSION 3 GRANTED
Friday, December 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 22, 2023SOU EXTENSION 4 FILED
Tuesday, June 27, 2023TEAS PETITION TO REVIVE RECEIVED
Tuesday, June 27, 2023PETITION TO REVIVE-GRANTED
Tuesday, June 27, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, June 28, 2023NOTICE OF REVIVAL - E-MAILED
Monday, August 7, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 7, 2023SOU EXTENSION 4 GRANTED
Tuesday, August 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 5, 2023SOU EXTENSION 5 FILED
Tuesday, December 12, 2023SOU EXTENSION 5 GRANTED
Wednesday, December 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 29, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 29, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

zibcleo gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric diseases disorders related